Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2020 16:05 ET | Source: Neovasc, Inc.

Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results

VANCOUVER and MINNEAPOLIS, March 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive...
March 17, 2020 09:00 ET | Source: Neovasc, Inc.

Neovasc to Report Fourth Quarter and Full Year 2019 Financial Results on March 30, 2020

VANCOUVER, March 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement...
March 04, 2020 09:00 ET | Source: Neovasc, Inc.

Neovasc Updates Investors at SVB Leerink 9th Annual Global Healthcare Conference

VANCOUVER, March 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
March 03, 2020 09:00 ET | Source: Neovasc, Inc.

Neovasc Reducer Featured in Peer Reviewed EuroIntervention and PCR Online

VANCOUVER, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
February 20, 2020 06:45 ET | Source: Neovasc, Inc.

Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff

VANCOUVER and MINNEAPOLIS, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive...
February 18, 2020 09:00 ET | Source: Neovasc, Inc.

Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020

VANCOUVER, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
February 12, 2020 09:30 ET | Source: Neovasc, Inc.

Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara™ Mitral Valve System

VANCOUVER and MINNEAPOLIS, Feb. 12, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive...
February 11, 2020 07:30 ET | Source: Neovasc, Inc.

Neovasc Initiates Independent Inquiry Into Trading of its Shares

Vancouver, Feb. 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
February 03, 2020 07:30 ET | Source: Neovasc, Inc.

Neovasc Provides Update on Nasdaq Compliance

VANCOUVER, Feb. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral...
January 31, 2020 09:00 ET | Source: Neovasc, Inc.

Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina

Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or...